Jupiter Asset Management Ltd. purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 6,737 shares of the medical equipment provider’s stock, valued at approximately $4,774,000.
Other hedge funds have also made changes to their positions in the company. Brookstone Capital Management purchased a new position in Intuitive Surgical during the 2nd quarter worth $240,000. Cerebellum GP LLC purchased a new position in Intuitive Surgical during the 2nd quarter worth $127,000. CWM LLC boosted its holdings in Intuitive Surgical by 11.3% during the 2nd quarter. CWM LLC now owns 689 shares of the medical equipment provider’s stock worth $393,000 after acquiring an additional 70 shares during the last quarter. Duncker Streett & Co. Inc. boosted its holdings in Intuitive Surgical by 54.1% during the 2nd quarter. Duncker Streett & Co. Inc. now owns 114 shares of the medical equipment provider’s stock worth $65,000 after acquiring an additional 40 shares during the last quarter. Finally, Creative Financial Designs Inc. ADV purchased a new position in Intuitive Surgical during the 2nd quarter worth $58,000. Institutional investors and hedge funds own 86.94% of the company’s stock.
In other news, Director Mark J. Rubash sold 1,000 shares of the company’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $723.73, for a total transaction of $723,730.00. Following the sale, the director now directly owns 5,560 shares in the company, valued at $4,023,938.80. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Alan J. Levy sold 1,800 shares of the company’s stock in a transaction dated Tuesday, October 20th. The shares were sold at an average price of $736.12, for a total value of $1,325,016.00. Over the last quarter, insiders have sold 10,050 shares of company stock worth $7,260,576. Company insiders own 1.60% of the company’s stock.
ISRG has been the topic of a number of analyst reports. Wolfe Research started coverage on shares of Intuitive Surgical in a report on Friday, September 11th. They set an “outperform” rating and a $789.00 price objective on the stock. BTIG Research reissued a “hold” rating on shares of Intuitive Surgical in a report on Thursday, October 15th. Robert W. Baird started coverage on shares of Intuitive Surgical in a report on Tuesday, September 1st. They issued a “neutral” rating and a $700.00 price target on the stock. Bank of America downgraded shares of Intuitive Surgical from a “buy” rating to a “neutral” rating and boosted their price target for the stock from $725.00 to $760.00 in a report on Tuesday, September 8th. Finally, BidaskClub raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 10th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Hold” and an average target price of $716.89.
Shares of ISRG opened at $730.74 on Friday. The business’s 50-day moving average price is $726.07 and its 200-day moving average price is $652.59. Intuitive Surgical, Inc. has a twelve month low of $360.50 and a twelve month high of $792.54. The stock has a market cap of $85.90 billion, a PE ratio of 83.23, a P/E/G ratio of 10.51 and a beta of 0.97.
Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 15th. The medical equipment provider reported $2.77 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.62 by $1.15. Intuitive Surgical had a return on equity of 12.08% and a net margin of 24.45%. The firm had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $966.81 million. During the same period in the prior year, the business posted $0.60 earnings per share. The company’s revenue was down 4.5% on a year-over-year basis. Equities analysts expect that Intuitive Surgical, Inc. will post 8.02 earnings per share for the current year.
Intuitive Surgical Profile
Intuitive Surgical, Inc, together with its subsidiaries, designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Featured Story: Overbought
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.